Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related decline in central cholinergic function demonstrated with scopolamine

P N Tariot1, S V Patel, C Cox

  • 1Department of Psychiatry, University of Rochester School of Medicine and Dentistry, New York, USA.

Psychopharmacology
|May 1, 1996
PubMed
Summary

Older adults show increased sensitivity to scopolamine, a drug affecting cognitive functions. This study found age significantly correlates with scopolamine-induced impairments in memory and motor skills.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning curves and breast cancer lymphatic mapping: institutional volume index.

The Journal of surgical research·2001
Same author

Encephalopathy associated with respiratory syncytial virus bronchiolitis.

Journal of child neurology·2001
Same author

Incidental discovery of pelvic cholelithiasis on diagnostic laparoscopy.

Surgical endoscopy·2001
Same author

Methylmercury and neurodevelopment: reanalysis of the Seychelles Child Development Study outcomes at 66 months of age.

JAMA·2001
Same author

Depression and self-reported functional status in older primary care patients.

The American journal of psychiatry·2001
Same author

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.

Neurology·2001

Area of Science:

  • Pharmacology
  • Neuroscience
  • Gerontology

Background:

  • Scopolamine is an anticholinergic drug known to induce cognitive deficits.
  • Aging is associated with changes in cognitive function and drug sensitivity.

Purpose of the Study:

  • To investigate the dose-dependent effects of scopolamine on cognitive functions in normal adults.
  • To examine the relationship between age and scopolamine-induced cognitive impairments.

Main Methods:

  • A double-blind, placebo-controlled, randomized study involving 23 normal subjects (40-89 years).
  • Intravenous administration of scopolamine hydrobromide at doses of 0.1 mg, 0.25 mg, and 0.5 mg.
  • Assessment using a comprehensive cognitive test battery, behavioral, and physiological measures.

Related Experiment Videos

Main Results:

  • Scopolamine caused dose-dependent cognitive impairments, particularly in psychomotor speed, short-term recall, visual tracking, visuo-motor coordination, and sequencing.
  • Age significantly correlated with scopolamine-impaired performances across multiple cognitive domains.
  • Behavioral and physiological effects were minimal, with some inter-individual variability observed.

Conclusions:

  • Cholinergically mediated cognitive functions exhibit heightened sensitivity to scopolamine in older adults.
  • Age-related increases in scopolamine sensitivity suggest potential implications for medication management in the elderly.
  • Further research is warranted to understand the heterogeneity of this age-related phenomenon.